Categories: Chemicals

Lyophilized Injectable Drugs Market Growth Outlook Through 2024-2033

Overview and Scope

Lyophilized injectable drugs, also known as freeze-dried drugs, are medications that have undergone the process of lyophilization. Lyophilization is a technique used to remove water from drugs by freezing them and then subjecting them to a vacuum, causing the frozen water to sublime directly from a solid state to a gas state. Lyophilized injection drugs improve bioavailability, stability, solubility, and patient compliance.

Sizing and Forecast

The lyophilized injectable drugs market size has grown steadily in recent years. It will grow from $3.82 billion in 2023 to $3.93 billion in 2024 at a compound annual growth rate (CAGR) of 3.0%. The growth in the historic period can be attributed to rise in chronic diseases, growing biopharmaceutical industry, expanding geriatric population, clinical advancements and trials, globalization of pharmaceutical manufacturing..

The lyophilized injectable drugs market size is expected to see steady growth in the next few years. It will grow to $4.48 billion in 2028 at a compound annual growth rate (CAGR) of 3.3%. The growth in the forecast period can be attributed to rise in personalized medicine, expansion of biologics pipeline, global health preparedness, demand for orphan drugs, increased focus on patient compliance.. Major trends in the forecast period include innovations in lyophilized combination therapies, expansion of lyophilized vaccines, integration of quality-by-design (qbd) principles, utilization of lyophilized drugs in emergency medicine, regulatory emphasis on lyophilization process validation..

To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/lyophilized-injectable-drugs-global-market-report

Segmentation & Regional Insights

The lyophilized injectable drugs market covered in this report is segmented –

1) By Packaging Type: Specialty Packaging, Point-Of-Care Reconstitution, Single-Use Vials, Other Packaging Types.
2) By Type of Delivery: Single-Step Devices, Multi-Step Devices, Prefilled Diluent Syringes, Proprietary Reconstitution Devices.
3) By Indication: Infectious Diseases, Autoimmune Diseases, Metabolic Conditions, Other Indications.
4) By End-User: Hospitals, Ambulatory Surgery Centers (ASCs), Specialty Clinics, Other End-Users.

North America was the largest region in the lyophilized injectable drugs market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lyophilized injectable drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=11896&type=smp

Major Driver Impacting Market Growth

The rising incidence of cardiac disorders is expected to propel the growth of the lyophilized injectable drugs market going forward. Cardiac disorders refer to a wide range of conditions that affect the structure and function of the heart, including the valves, chambers, blood arteries, electrical system, and general pumping function. Lyophilized injectable drugs such as thrombolytic agents, antiarrhythmic medications, inotropic agents, and antihypertensive medications are used in the treatment of various cardiac disorders as they provide stability, convenience, and flexibility, rapid reconstitution, improved bioavailability, and reduced risk of contamination. Hence, the lyophilized injectable drugs market is growing because of increased cardiac disorders globally. For instance, in May 2023, according to the Centers for Disease Control and Prevention Highlights, a US-based intergovernmental organization, coronary heart disease was estimated to kill 375,476 people in 2021. Furthermore, in December 2022, according to data published by New York government, in the United States, heart disease claims the lives of about 697,000 people annually, or 1 in every 5 fatalities where around 805,000 Americans experience a heart attack each year among which 605,000 of these result in a first-time heart attack, while 200,000 are caused by previous heart attacks. Therefore, the rising incidence of cardiac disorders drives the growth of the lyophilized injectable drugs market during the forecast period.

Key Industry Players

Major companies operating in the lyophilized injectable drugs market report are Pfizer Inc., Hoffmann-La Roche Ltd, Merck & Co Inc., Sanofi SA, Novo Nordisk A/S, Becton Dickinson and Company, Baxter International Inc., Sandoz, Nipro Corporation, B. Braun SE, Aurobindo Pharmaceuticals, Schott AG, Zydus Lifesciences, Recipharm AB, Vetter Pharma-Fertigung GmbH & Co. KG, Fresenius Kabi USA LLC, Vetter Pharma-Fertigung GmbH & Co. KG, CordenPharma International, Aristopharma Limited., Accord Healthcare, Jubilant HollisterStier LLC, Ciron Drugs & Pharmaceuticals Pvt Ltd., MSN Laboratories, Qilu pharmaceutical Co Ltd., Genex Pharma

The lyophilized injectable drugs market report table of contents includes:

1. Executive Summary

2. Lyophilized Injectable Drugs Market Characteristics

3. Lyophilized Injectable Drugs Market Trends And Strategies

4. Lyophilized Injectable Drugs Market – Macro Economic Scenario

5. Global Lyophilized Injectable Drugs Market Size and Growth

…

32. Global Lyophilized Injectable Drugs Market Competitive Benchmarking

33. Global Lyophilized Injectable Drugs Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Lyophilized Injectable Drugs Market

35. Lyophilized Injectable Drugs Market Future Outlook and Potential Analysis

36. Appendix